Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

BMC cancer

Volumn 14, Issue , 2014, Pages 550-

  Horimoto, Yoshiya ^a   Arakawa, Atsushi ^a   Tanabe, Masahiko ^a   Sonoue, Hiroshi ^a   Igari, Fumie ^a   Senuma, Koji ^a   Tokuda, Emi ^a   Shimizu, Hideo ^a   Kosaka, Taijiro ^a   Saito, Mitsue ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; KI 67 ANTIGEN;

ADJUVANT THERAPY; BREAST NEOPLASMS; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOADJUVANT THERAPY; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904853009     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-550     Document Type: Article

References (0)